Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

Safety, tolerability and antiviral efficacy of GW-695634 in NNRTI-resistant HIV-1-infected patients

Aug. 23, 2005

Antiretroviral efficacy of stampidine is evident in FIV-infected cats

Aug. 23, 2005

WHI-07 alone or in combination with vanadocene protects cats from FIV

Aug. 22, 2005

Combination of microbicides CAP and UC-781 synergistically inhibits HIV-1 replication

Aug. 22, 2005

Thiovir effective against resistant HIV-1 strains and synergistic with zidovudine

Aug. 18, 2005

Antiviral efficacy and pharmacokinetics of vicriviroc alone or in combination with other antivirals

Aug. 18, 2005

Antiviral efficacy and pharmacokinetics of single-oral dose PA-457 reported in HIV-infected patients

Aug. 18, 2005

Bioequivalence studies continue for fixed-dose Truvada/Sustiva product

Aug. 16, 2005

New anti-HIV agents described in recent Pfizer patent

Aug. 10, 2005

Harvard and Crucell receive NIH grant for next-generation AdVac vaccines for HIV/AIDS

Aug. 3, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
Capital remains selective in ‘barbell’ biotech market
BioWorld
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...
PSB-229 reduces plaque burden in Alzheimer’s models
BioWorld Science
Pyroglutamate-modified amyloid-β (pE3-Aβ) is a highly pathogenic Aβ species that accumulates within amyloid plaques and contributes to aggregation,...